G319-0232 Screening compound: N,3-diphenyl-2-(quinoline-8-sulfonamido)propanamide

G319-0232 Screening compound: N,3-diphenyl-2-(quinoline-8-sulfonamido)propanamide
G319-0232 Screening compound: N,3-diphenyl-2-(quinoline-8-sulfonamido)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G319-0232
N,3-diphenyl-2-(quinoline-8-sulfonamido)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G319-0232

Molecular Formula

C24H21N3O3S (C24 H21 N3 O3 S)

Compound Name

N,3-diphenyl-2-(quinoline-8-sulfonamido)propanamide

IUPAC name

N3-diphenyl-2-(quinoline-8-sulfonamido)propanamide

SMILES

O=C(C(Cc1ccccc1)NS(c1cccc2cccnc12)(=O)=O)Nc1ccccc1

InChI

InChI=1S/C24H21N3O3S/c28-24(26-20-13-5-2-6-14-20)21(17-18-9-3-1-4-10-18)27-31(29,30)22-15-7-11-19-12-8-16-25-23(19)22/h1-16,21,27H,17H2,(H,26,28)/t21-/m0/s1

InChI Key

BGFDPSAWVYYBHE-NRFANRHFSA-N

MDL Number (MFCD)

MFCD14997463

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

431.52

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.464

Distribution Coefficient, logD

3.463

Water Solubility, LogSw

-3.47

Polar Surface Area

74.465

Acid Dissociation Constant (pKa)

9.86

Base Dissociation Constant (pKb)

-0.65

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

8.30

G319-0232 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Integrin Receptors Targeted library (1715 compounds)

Nucleic Acid Ligands (8311 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Others
  • Others
  • Proteases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with G319-0232 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G319-0232?
Check Price and Availability of G319-0232, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G319-0232 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G319-0232
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G319-0232
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G319-0232 available by request